CDMO Market Forces Re-shape of Mergers and Acquisitions Activity
by Jim Miller, Content Advisor and Consultant, DCAT
The emergence of mega-contract development and manufacturing organizations (CDMOs), limited acquisition targets of CDMOs due to tight capacity, and burgeoning trade issues are key issues influencing deal-making in the CDMO market.
Executive Moves: What Lies Ahead for Sanofi's New CEO
by Patricia Van Arnum, DCAT Editorial Director
Sanofi CEO Olivier Brandicourt has announced plans to retire, effective September 1, with Paul Hudson, head of Novartis' pharmaceutical division, taking the helm. With Sanofi facing competition in its diabetes-drug franchise and recent moves in rare diseases, what are the challenges and opportunities for the new CEO? Read More
Patricia Van Arnum is Editorial Director at the Drug, Chemical & Associated Technologies Association (DCAT), where she is responsible for delivering informational services for DCAT members. She is editor of two weekly editorial newsletters, DCAT Value Chain Insights and Top Industry News. She also supports DCAT’s volunteer committees and task forces that develop educational programs and informational content for DCAT members. Read More
DCAT Value Chain Insights is produced and distributed by the Drug, Chemical and Associated Technologies Association.